Free Trial

Rapport Therapeutics (RAPP) to Release Earnings on Thursday

Rapport Therapeutics logo with Medical background

Rapport Therapeutics (NASDAQ:RAPP - Get Free Report) is expected to post its quarterly earnings results on Thursday, February 6th. Analysts expect Rapport Therapeutics to post earnings of ($0.62) per share for the quarter.

Rapport Therapeutics (NASDAQ:RAPP - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.50) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.07. On average, analysts expect Rapport Therapeutics to post $-4 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Rapport Therapeutics Price Performance

Shares of Rapport Therapeutics stock traded up $1.36 during trading on Thursday, hitting $16.99. 45,459 shares of the company were exchanged, compared to its average volume of 96,801. The firm's fifty day moving average price is $18.03 and its 200 day moving average price is $20.62. Rapport Therapeutics has a 1-year low of $12.09 and a 1-year high of $29.74.

Rapport Therapeutics Company Profile

(Get Free Report)

Rapport Therapeutics Inc is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc is based in BOSTON.

See Also

Should You Invest $1,000 in Rapport Therapeutics Right Now?

Before you consider Rapport Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapport Therapeutics wasn't on the list.

While Rapport Therapeutics currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines